Cargando…

Seizure after surgical treatment of chronic subdural hematoma—Associated factors and effect on outcome

INTRODUCTION: Chronic subdural hematoma (cSDH) is becoming more prevalent due to population aging and the increasing use of antithrombotic drugs. Postoperative seizure in cSDH have a negative effect on outcome, and there currently no consensus regarding prophylactic anti-epileptic drug (AED) treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamou, Hussam, Alzaiyani, Mohammed, Rossmann, Tobias, Pjontek, Rastislav, Kremer, Benedikt, Zaytoun, Hasan, Ridwan, Hani, Clusmann, Hans, Hoellig, Anke, Veldeman, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493299/
https://www.ncbi.nlm.nih.gov/pubmed/36158969
http://dx.doi.org/10.3389/fneur.2022.977329
_version_ 1784793685144109056
author Hamou, Hussam
Alzaiyani, Mohammed
Rossmann, Tobias
Pjontek, Rastislav
Kremer, Benedikt
Zaytoun, Hasan
Ridwan, Hani
Clusmann, Hans
Hoellig, Anke
Veldeman, Michael
author_facet Hamou, Hussam
Alzaiyani, Mohammed
Rossmann, Tobias
Pjontek, Rastislav
Kremer, Benedikt
Zaytoun, Hasan
Ridwan, Hani
Clusmann, Hans
Hoellig, Anke
Veldeman, Michael
author_sort Hamou, Hussam
collection PubMed
description INTRODUCTION: Chronic subdural hematoma (cSDH) is becoming more prevalent due to population aging and the increasing use of antithrombotic drugs. Postoperative seizure in cSDH have a negative effect on outcome, and there currently no consensus regarding prophylactic anti-epileptic drug (AED) treatment. The objective of this study was to evaluate predisposing and triggering factors associated with postoperative epileptic seizure in patients with cSDH. METHODS: All patients, who were surgically treated for cSDH in a single tertiary care center between 2015 and 2019, were considered for inclusion. Relevant patient- and hematoma-specific characteristics were retrospectively extracted from hospital records. Paroxysmal events categorized by the treating physician as suspected postoperative seizures were noted. The clinical outcome was extracted from the last available follow-up visit and classified according to the Glasgow outcome scale (GOS). RESULTS: Of the included 349 patients, 54 (15.5%) developed suspected postoperative epileptic complications in the form of early seizure (≤ 7 days) in 11 patients (3.2%) and late seizure (>7 days) in 43 patients (12.3%). In the logistic regression analysis, solely depressed brain volume (supratentorial volume (ml) not filled with re-expanded brain) was independently associated with postoperative seizure (odds ratio [OR] 1.006, 95% CI: 1.001–1.011; p = 0.034). The occurrence of postoperative seizure (OR 6.210, 95% CI: 2.704–14.258; p < 0.001) and preoperative Markwalder grading (OR 2.919, 95% CI: 1.538–5.543; p = 0.001) were independently associated with unfavorable (GOS(1−3)) outcome. CONCLUSION: Larger postoperative depressed brain volume was the only factor independently associated with suspected postoperative seizure, and it could help identify a subgroup of patients with higher susceptibility to epileptic events. Based on our data, no formal recommendation can be made regarding the prophylactic use of anti-epileptic drugs. Nevertheless, the relative safety of new generation AEDs and the detrimental effect of postoperative seizure on outcome may justify its use in a selected patient population.
format Online
Article
Text
id pubmed-9493299
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94932992022-09-23 Seizure after surgical treatment of chronic subdural hematoma—Associated factors and effect on outcome Hamou, Hussam Alzaiyani, Mohammed Rossmann, Tobias Pjontek, Rastislav Kremer, Benedikt Zaytoun, Hasan Ridwan, Hani Clusmann, Hans Hoellig, Anke Veldeman, Michael Front Neurol Neurology INTRODUCTION: Chronic subdural hematoma (cSDH) is becoming more prevalent due to population aging and the increasing use of antithrombotic drugs. Postoperative seizure in cSDH have a negative effect on outcome, and there currently no consensus regarding prophylactic anti-epileptic drug (AED) treatment. The objective of this study was to evaluate predisposing and triggering factors associated with postoperative epileptic seizure in patients with cSDH. METHODS: All patients, who were surgically treated for cSDH in a single tertiary care center between 2015 and 2019, were considered for inclusion. Relevant patient- and hematoma-specific characteristics were retrospectively extracted from hospital records. Paroxysmal events categorized by the treating physician as suspected postoperative seizures were noted. The clinical outcome was extracted from the last available follow-up visit and classified according to the Glasgow outcome scale (GOS). RESULTS: Of the included 349 patients, 54 (15.5%) developed suspected postoperative epileptic complications in the form of early seizure (≤ 7 days) in 11 patients (3.2%) and late seizure (>7 days) in 43 patients (12.3%). In the logistic regression analysis, solely depressed brain volume (supratentorial volume (ml) not filled with re-expanded brain) was independently associated with postoperative seizure (odds ratio [OR] 1.006, 95% CI: 1.001–1.011; p = 0.034). The occurrence of postoperative seizure (OR 6.210, 95% CI: 2.704–14.258; p < 0.001) and preoperative Markwalder grading (OR 2.919, 95% CI: 1.538–5.543; p = 0.001) were independently associated with unfavorable (GOS(1−3)) outcome. CONCLUSION: Larger postoperative depressed brain volume was the only factor independently associated with suspected postoperative seizure, and it could help identify a subgroup of patients with higher susceptibility to epileptic events. Based on our data, no formal recommendation can be made regarding the prophylactic use of anti-epileptic drugs. Nevertheless, the relative safety of new generation AEDs and the detrimental effect of postoperative seizure on outcome may justify its use in a selected patient population. Frontiers Media S.A. 2022-09-08 /pmc/articles/PMC9493299/ /pubmed/36158969 http://dx.doi.org/10.3389/fneur.2022.977329 Text en Copyright © 2022 Hamou, Alzaiyani, Rossmann, Pjontek, Kremer, Zaytoun, Ridwan, Clusmann, Hoellig and Veldeman. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Hamou, Hussam
Alzaiyani, Mohammed
Rossmann, Tobias
Pjontek, Rastislav
Kremer, Benedikt
Zaytoun, Hasan
Ridwan, Hani
Clusmann, Hans
Hoellig, Anke
Veldeman, Michael
Seizure after surgical treatment of chronic subdural hematoma—Associated factors and effect on outcome
title Seizure after surgical treatment of chronic subdural hematoma—Associated factors and effect on outcome
title_full Seizure after surgical treatment of chronic subdural hematoma—Associated factors and effect on outcome
title_fullStr Seizure after surgical treatment of chronic subdural hematoma—Associated factors and effect on outcome
title_full_unstemmed Seizure after surgical treatment of chronic subdural hematoma—Associated factors and effect on outcome
title_short Seizure after surgical treatment of chronic subdural hematoma—Associated factors and effect on outcome
title_sort seizure after surgical treatment of chronic subdural hematoma—associated factors and effect on outcome
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493299/
https://www.ncbi.nlm.nih.gov/pubmed/36158969
http://dx.doi.org/10.3389/fneur.2022.977329
work_keys_str_mv AT hamouhussam seizureaftersurgicaltreatmentofchronicsubduralhematomaassociatedfactorsandeffectonoutcome
AT alzaiyanimohammed seizureaftersurgicaltreatmentofchronicsubduralhematomaassociatedfactorsandeffectonoutcome
AT rossmanntobias seizureaftersurgicaltreatmentofchronicsubduralhematomaassociatedfactorsandeffectonoutcome
AT pjontekrastislav seizureaftersurgicaltreatmentofchronicsubduralhematomaassociatedfactorsandeffectonoutcome
AT kremerbenedikt seizureaftersurgicaltreatmentofchronicsubduralhematomaassociatedfactorsandeffectonoutcome
AT zaytounhasan seizureaftersurgicaltreatmentofchronicsubduralhematomaassociatedfactorsandeffectonoutcome
AT ridwanhani seizureaftersurgicaltreatmentofchronicsubduralhematomaassociatedfactorsandeffectonoutcome
AT clusmannhans seizureaftersurgicaltreatmentofchronicsubduralhematomaassociatedfactorsandeffectonoutcome
AT hoelliganke seizureaftersurgicaltreatmentofchronicsubduralhematomaassociatedfactorsandeffectonoutcome
AT veldemanmichael seizureaftersurgicaltreatmentofchronicsubduralhematomaassociatedfactorsandeffectonoutcome